Fluticasone nasal 50 mcg — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Rhinosinusitis (Symptomatic)

• Oxymetazoline
• Oxymetazoline 0.05% nasal (short-term)

About Fluticasone nasal 50 mcg

Suffering from seasonal or perennial allergies? Fluticasone nasal 50 mcg can be a powerful ally against sneezing, congestion, and itchy noses. At TheDrugClub, we believe essential medications like this shouldn't break the bank. If you're among the millions who experience the misery of seasonal allergies (hay fever) or perennial allergies that strike year-round, you're likely familiar with the constant battle against sneezing, runny nose, nasal congestion, and itchy eyes. Fluticasone nasal 50 mcg is a widely prescribed and highly effective medication designed to combat these very symptoms, helping you find lasting relief. ### What Fluticasone Nasal 50 mcg Treats

Fluticasone nasal 50 mcg is primarily used to treat the symptoms of allergic rhinitis, commonly known as allergies. Whether your allergies are triggered by pollen, dust mites, pet dander, or mold, this medication can significantly reduce your discomfort. It's effective for both seasonal allergies, which flare up during specific times of the year, and perennial allergies, which persist throughout the year. Users typically experience a reduction in sneezing, nasal itching, runny nose, and nasal stuffiness, leading to clearer breathing and improved quality of life. ### How It Works to Provide Relief

Unlike oral antihistamines that block histamine, fluticasone nasal 50 mcg belongs to a class of medications called corticosteroids. When sprayed into the nose, it works directly on the nasal passages to reduce inflammation and swelling. This anti-inflammatory action helps to prevent and alleviate the allergic reactions that cause your symptoms. It's important to use it consistently, as directed by your doctor, to achieve its full preventative and therapeutic effects. Regular use helps to keep the nasal passages clear and reduce the severity of allergy symptoms over time. ### Understanding Typical Costs

As a generic medication, fluticasone nasal 50 mcg is generally more affordable than its brand-name counterparts. However, the cost can still vary significantly depending on your insurance coverage, the pharmacy you choose, and your location. Without insurance or a discount program, a single prescription can typically range anywhere from $20 to $50 or more per month. These costs can add up, especially for those who rely on the medication year-round

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Fluticasone nasal 50 mcg is approved for (FDA label)

Fluticasone propionate nasal spray is indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adults and pediatric patients aged 4 years and older. Fluticasone propionate nasal spray is a corticosteroid indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older. ( 1 )

Source: Read the full FDA label on DailyMed. Label effective date: August 19, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Fluticasone nasal 50 mcg (FDA label)

Fluticasone propionate nasal spray, USP is a white, opaque, uniform, aqueous suspension free from any visible foreign matter or agglomerates. Each 100 mg spray delivers 50 mcg of fluticasone propionate, USP. Nasal spray: 50 mcg of fluticasone propionate, USP in each 100 mg spray. ( 3 )

Source: FDA prescribing information (DailyMed). Set ID: bc08915f-fa3a-4509-a01c-42b577f39b99. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Fluticasone nasal 50 mcg (FDA label)

Systemic and local corticosteroid use may result in the following: • Epistaxis, nasal ulceration, Candida albicans infection, nasal septal perforation, and impaired wound healing [see Warnings and Precautions ( 5.1 )] • Glaucoma and cataracts [see Warnings and Precautions ( 5.2 )] • Immunosuppression [see Warnings and Precautions ( 5.4 )] • Hypercorticism and adrenal suppression [see Warnings and Precautions ( 5.5 )] • Effect on growth [see Warnings and Precautions ( 5.7 )] The most common adverse reactions (>3%) are headache, pharyngitis, epistaxis, nasal burning/nasal irritation, nausea/vomiting, asthma symptoms, and cough. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Glenmark Pharmaceuticals Inc., USA at 1 (888) 721-7115 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Source: FDA prescribing information (DailyMed). Set ID: bc08915f-fa3a-4509-a01c-42b577f39b99. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Fluticasone nasal 50 mcg (FDA label)

Fluticasone propionate nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients [see Warnings and Precautions ( 5.3 ) , Description ( 11 )] . Hypersensitivity to any ingredient. ( 4 )

Source: FDA prescribing information (DailyMed). Set ID: bc08915f-fa3a-4509-a01c-42b577f39b99. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Fluticasone nasal 50 mcg (FDA label)

• Epistaxis, nasal ulceration, Candida albicans infection, nasal septal perforation, and impaired wound healing. Monitor patients periodically for signs of adverse effects on the nasal mucosa. Avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma. ( 5.1 ) • Glaucoma and cataracts: Consider referral to an ophthalmologist in patients who develop ocular symptoms or use fluticasone propionate nasal spray long-term. ( 5.2 ) • Hypersensitivity reactions (e.g., anaphylaxis, angioedema, urticaria, contact dermatitis, and rash) have been reported after administration of fluticasone propionate nasal spray. Discontinue fluticasone propionate nasal spray if such reactions occur. ( 5.3 ) • Potential worsening of infections (e.g., existing tuberculosis; fungal, bacterial, viral, or parasitic infection; ocular herpes simplex). Use with caution in patients with these infections.

Source: FDA prescribing information (DailyMed). Set ID: bc08915f-fa3a-4509-a01c-42b577f39b99. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Fluticasone nasal 50 mcg (FDA label)

Strong cytochrome P450 3A4 inhibitors (e.g., ritonavir, ketoconazole): Use not recommended. May increase risk of systemic corticosteroid effects. ( 7.1 ) 7.1 Inhibitors of Cytochrome P450 3A4 Fluticasone propionate is a substrate of CYP3A4. The use of strong CYP3A4 inhibitors (e.g., ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, ketoconazole, telithromycin, conivaptan, lopinavir, nefazodone, voriconazole) with fluticasone propionate nasal spray is not recommended because increased systemic corticosteroid adverse effects may occur. Ritonavir : A drug interaction trial with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a strong CYP3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations [see Clinical Pharmacology ( 12.3 )]. During postmarketing use, there have been reports of clinically significant drug interactions in patients receiving fluticasone propionate products, including fluticasone propionate nasal spray, with ritonavir, resulting in systemic corticosteroid effects including Cushing’s syndrome and adrenal suppression.

Source: FDA prescribing information (DailyMed). Set ID: bc08915f-fa3a-4509-a01c-42b577f39b99. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.